Teva’s Austedo fails in two paediatric Tourette’s syndrome trials
February 21, 2020Medical Communications, Research and Development Austedo, Teva, pharma, tourette's
Israeli firm Teva has shared disappointing results for its vesicular monoamine transporter 2 (VMAT2) Austedo (deutetrabenazine) after it failed to …
Top Ten most popular articles on Pharmafile.com this week
February 21, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug market, Europe, coronavirus, opioid crisis, opioids
The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens …
Ukrainian protestors attack bus carrying Chinese evacuees from Wuhan
February 21, 2020Medical Communications Chinese Coronavirus, MERS, Sars, Wuhan, Wuhan Coronavirus, coronavirus
On Thursday, Ukrainian protestors attacked buses carrying people evacuated from Wuhan in China, the epicenter of the coronavirus outbreak. The …
New antibiotic discovered by AI for the first time
February 21, 2020Medical Communications AI, AI Clinical Trials, AI Drugs, AI antibiotics, MIT, algorithm, clinical trials
MIT researchers have identified a new antibiotic compound using a machine-learning algorithm. In the laboratory tests, the drug killed many …
New Keytruda dosing schedule rejected in six cancers by the FDA
February 20, 2020Sales and Marketing Cancer, FDA, MSD, keytruda, pharma
MSD’s blockbuster immunotherapy Keytruda has been stopped in its tracks by the FDA after the US regulator rejected its application …
Bristol-Myers Squibb demonstrates potential for long-term survival in kidney cancer patients treated with Opdivo plus Yervoy
February 20, 2020Business Services Cancer, Cancers, Yervoy, opdivo, renacl cell carcinoma, renal cancer
Bristol-Myers Squibb has announced updated results from trialing Opdivo (nivolumab) plus Yervoy (ipilimumab) versus sunitinib in patients with previously untreated …
GlaxoSmithKline acquires two solid tumor cell therapies from Immatics for $50 million
February 20, 2020Business Services Cancer, cancer cells, celluar immunotherapies, immunotherapies
GlaxoSmithKline has struck a deal to access two Immatics T-cell receptor (TCR) therapeutics. The deal sees GSK pay $50 million …
FDA approved over 1,000 generic drugs in 2019
February 20, 2020Research and Development, Sales and Marketing FDA, generic drugs, pharma
The FDA covered a lot of ground in 2019 when it came to generic drugs, awarding at least tentative approval …
Two passengers with coronavirus die on quarantined cruise ship in Japan
February 20, 2020Business Services Chinese Coronavirus, MARS, Sars, Wuhan, Wuhan Coronavirus, coronavirus
Two Japanese passengers on a quarantined cruise ship have died after contracting the coronavirus.The pair were both in their 80’s …
Europe approves first treatment for transthyretin amyloidosis in cardiomyopathy patients: Pfizer’s Vyndaqel
February 19, 2020Research and Development, Sales and Marketing Europe, Pfizer, Vyndaqel, pharma, transthyretin amyloidosis
The European Commission (EC) has awarded marketing approval to Pfizer’s Vyndaqel (tafamidis), it has emerged, for the treatment of wild-type …
CEO of PixarBio Corporation sentenced to prison for defrauding investors
February 19, 2020Research and Development Biopharmaceuticals, CEO, FDA, corruption, fraud, investors
Frank Reynolds, the CEO of Boston based PixarBio Corporation, was sentenced to seven years in prison for defrauding investors and …
FDA teams up with Indian government to crack down on illicit drugs shipments
February 19, 2020Research and Development FDA, FDA India, FDA trade, Indian Pharma
The FDA announced yesterday its first successful bilateral enforcement operation with the Government of India, where they stopped 500 shipments …
Opdivo + cabiralizumab combo falls flat in advanced pancreatic cancer
February 19, 2020Research and Development Bristol-Myers Squibb, Five Prime Therapeutics, Pancreatic cancer, cabiralizumab, opdivo, pharma
Five Prime Therapeutics and Bristol-Myers Squibb have confirmed that their randomised Phase 2 trial investigating the efficacy of the former’s …
Women who take statins could be less likely to develop ovarian cancer, study finds
February 19, 2020Research and Development, Sales and Marketing Cancer, Cancer Research UK, cholesterol, ovarian cancer, statins
A study by Cancer Research UK has found that women who take statins, drugs that lower cholesterol, are less likely …
Janssen shows off Phase 3b interim data for Stelara in Crohn’s disease
February 18, 2020Manufacturing and Production, Research and Development Crohn’s disease, Janssen, Stelara, crohn's disease, pharma
Janssen has revealed new interim Phase 3b data from a study investigating the efficacy of Stelara (ustekinumab) in the treatment …
Scottish Medicines Consortium enables access to treatment for rare inherited bone disorder in children
February 18, 2020Manufacturing and Production Crysvita, Kyowa Kirin, SMC, Scottish Medicine Consortium, nhs scotland
The Scottish Medicines Consortium (SMC) has enabled access to Kyowa Kirin’s Crysvita (burosumab) for the NHS in Scotland to treat …
Novartis’ Beovu approved in Europe after outclassing Eylea in wet age-related macular degeneration
February 18, 2020Manufacturing and Production, Sales and Marketing Beovu, Eylea, Novartis, Regeneron, macular degeneration, pharma
The European Commission (EC) has chosen to approve Novartis’ Beovu (brolucizumab) injection, it has emerged, as a treatment for wet …
NICE gives initial ‘no’ to NHS England for kidney cancer drug
February 18, 2020Manufacturing and Production NHS England, NICE, clinical trials, inlyta, keytruda
The National Institute for Health and Care Excellence (NICE) has not recommended Keytruda (pembrolizumab) and Inlyta (axitinib) for the treatment …
Rapid testing to help combat worst UK outbreak of HIV in 30 years
February 18, 2020Manufacturing and Production AIDS, HIV, HIV England, HIV Scotland, HIV epidemic, HIV/AIDS
New HIV tests that provide results in minutes are being used in Glasgow to fight a recent outbreak of HIV. …
Patient Experience: Living with multiple rare diseases
February 17, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, pharma, rare disease
Carole Scrafton discusses her experience living with Ehlers-Danlos syndrome alongside other rare conditions that have manifested throughout her life, and …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
